Contents 3 min read
Claim and source comparison
Ginseng: an acute G115 trial, two cognitive reviews and the NIH safety summary. Species and extracts are not treated as equivalent.
· Bounded source comparison; not a complete clinical review or independent medical endorsement.
Human randomized controlled trial
Reay et al. (2005) compared placebo, 200 mg and 400 mg G115 extract in a crossover trial in 30 healthy young adults. Some serial-subtraction and subjective mental-fatigue measures improved with 200 mg; blood glucose decreased with both amounts.
This single-dose task experiment does not establish lasting cognitive benefit or diabetes treatment. The abstract states that the cognitive mechanism is unknown; glucose changes do not prove a mechanism.
Source 1 · Abstract read
Systematic review / meta-analysis
The Geng et al. review assessed 5 trials with extractable data out of 9 eligible studies; all 5 involved healthy participants. Differences in outcomes, duration and dose prevented pooling.
The review found no convincing general cognitive benefit in healthy people or high-quality efficacy evidence in dementia. This older review must be read alongside later research.
Source 4 · Official summary read
Systematic review / meta-analysis
Zeng et al. (2024) analyzed 671 people in 15 randomized trials involving different participant groups. A small memory difference was reported (SMD 0.19; 95% CI 0.02–0.36); overall cognition, attention and executive function showed no significant difference.
The abstract combines healthy people, patient groups and different preparations. The result is not the effect of a single Panax ginseng product; subgroup findings do not support a personal high-dose recommendation.
Source 5 · Abstract read
Official safety summary
NIH NCCIH states that Asian ginseng may lower blood glucose, affect clotting and worsen autoimmune disorders. Insomnia is the most commonly reported adverse effect; people taking medicines should consult a health professional.
Short-term observations do not establish long-term safety. Possible pregnancy risks are noted; breastfeeding safety is poorly known. Glucose and clotting warnings do not determine interaction magnitude for every medicine.
Source 6 · Official summary read
Correction · 2026-11-11. The acute G115 trial was separated from the older and 2024 reviews. General-dose and definite-mechanism statements were removed; glucose, clotting and autoimmune warnings were sourced.
What is Panax Ginseng?
Small acute trials of Panax ginseng measured mental fatigue and test performance. They do not establish sustained cognitive enhancement; Panax quinquefolius findings do not directly transfer to Korean ginseng, a different species.
Mechanism of Effect
This single-dose task experiment does not establish lasting cognitive benefit or diabetes treatment. The abstract states that the cognitive mechanism is unknown; glucose changes do not prove a mechanism.
Clinical Evidence
Reay et al. (2005) compared placebo, 200 mg and 400 mg G115 extract in a crossover trial in 30 healthy young adults. Some serial-subtraction and subjective mental-fatigue measures improved with 200 mg; blood glucose decreased with both amounts.
The Geng et al. review assessed 5 trials with extractable data out of 9 eligible studies; all 5 involved healthy participants. Differences in outcomes, duration and dose prevented pooling.
The review found no convincing general cognitive benefit in healthy people or high-quality efficacy evidence in dementia. This older review must be read alongside later research.
Zeng et al. (2024) analyzed 671 people in 15 randomized trials involving different participant groups. A small memory difference was reported (SMD 0.19; 95% CI 0.02–0.36); overall cognition, attention and executive function showed no significant difference.
The abstract combines healthy people, patient groups and different preparations. The result is not the effect of a single Panax ginseng product; subgroup findings do not support a personal high-dose recommendation.
⚠ Research Limitations
Ginseng studies may produce inconsistent results due to differences in extract standardization (ginsenoside ratios). Evidence for long-term cognitive benefits is still limited and larger, standardized studies are needed.
Dose information and research limits
Dose information and research limits
This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.
Controlled human trials have not established that specific on/off cycles prevent tolerance. Drug or supplement frequency should not be set by a personal online protocol.
Safety and Side Effects
NIH NCCIH states that Asian ginseng may lower blood glucose, affect clotting and worsen autoimmune disorders. Insomnia is the most commonly reported adverse effect; people taking medicines should consult a health professional.
Short-term observations do not establish long-term safety. Possible pregnancy risks are noted; breastfeeding safety is poorly known. Glucose and clotting warnings do not determine interaction magnitude for every medicine.
Related research and reading
These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.
Educational guides
- Dopamine and Motivation: Limits of Nootropic Evidence
Dopamine contributes to motivation; L-tyrosine and Mucuna studies do not establish general motivation gains or a safe dopamine protocol for healthy people.
- Caffeine and L-Theanine: Attention Studies and Their Limits
Small studies have examined some attention measures; a universal ideal ratio, prevention of caffeine side effects or safe use for everyone has not been established.
- Nootropic Cycling: Evidence and Limits
Tolerance, dependence and withdrawal are different phenomena. Breaks may be considered for some substances, but there is no validated cycling schedule for all nootropics.
Sources
- Reay JL, Kennedy DO, Scholey AB. (2005). Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of Psychopharmacology, 19(4), 357–365. PubMed · PMID 15982990
- Scholey A, et al. (2010). Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology, 212(3), 345–356. PubMed · PMID 20676609
- Kennedy DO, Scholey AB. (2003). Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacology Biochemistry and Behavior, 75(3), 687–700. PubMed · PMID 12895687
- Geng J, et al. (2010). Ginseng for cognition. Cochrane Database of Systematic Reviews, (12), CD007769. PubMed · PMID 21154383
- Zeng M, et al. (2024). Effects of Ginseng on Cognitive Function: A Systematic Review and Meta-Analysis. Phytotherapy Research, 38(12), 6023–6034. PubMed · PMID 39474788
- National Center for Complementary and Integrative Health. Asian Ginseng: Usefulness and Safety. https://www.nccih.nih.gov/health/asian-ginseng NIH NCCIH
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
Small acute trials of Panax ginseng measured mental fatigue and test performance. They do not establish sustained cognitive enhancement; Panax quinquefolius findings do not directly transfer to Korean ginseng, a different species.
This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.
NIH NCCIH states that Asian ginseng may lower blood glucose, affect clotting and worsen autoimmune disorders. Insomnia is the most commonly reported adverse effect; people taking medicines should consult a health professional.
Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.
No established timeframe